Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

In this week’s Phispers, Merck struck a US$ 9.2 billion deal to acquire Cidara Therapeutics to strengthen its infectious-...

Impressions : 494

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

In Phispers this week, Pfizer won its high stakes battle with Novo Nordisk for the obesity-focused biotech Metsera. The deal i...

Impressions : 951

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

As we return from our one-week break due to the CPhI Worldwide, we find our double-dose Phispers edition to be filled with se...

Impressions : 939

Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo's Rybelsus to reduce heart risk in diabetics

In this week’s Phispers, China’s Innovent Biologics signed one of the largest cross-border biotech deals in Asia. U...

Impressions : 1006

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause

Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo's Rybelsus to reduce heart risk in diabetics

Arrowhead Pharma's Redemplo Receives Approval in US

Marksans Pharma's Generics Loperamide HCl Receives Approval in US

Biocon's Generics Tofacitinib Receives Tentative Approval in US

Mylan's Generics Aprepitant Receives Tentative Approval in US

Hainan Poly Pharm's Generics Voriconazole Receives Approval in US

Accord's Generics Lenalidomide Receives Approval in US

Alembic's Generics Diltiazem HCl Receives Approval in US

Aurobindo Pharma's Generics Fosfomycin Receives Approval in US

Navinta's Generics Diazepam Receives Approval in US

Apotex's Generics Rivaroxaban Receives Approval in US

RNA Bio/Pharma's Recieves FDA Warning Letter

Cdymax's Receives FDA Warning Letter

Medical Mega's Receives FDA Warning Letter

Save Rite Medical's Receives FDA Warning Letter

World Perfumes' Receives FDA Warning Letter

Shoplet's Receives FDA Warning Letter

Sinsin's Receives FDA Warning Letter

Verdure's Receives FDA Warning Letter

Uriel Pharmacy's Receives FDA Warning Letter

DermaRite Industries' Receives FDA Warning Letter

Mankind Pharma Signs Licensing Deal With Actimed For Cachexia

Innovent Bio's Weight-Loss Drug Succeeds In Phase 3 Trial

Genscript Biotech Global Forum London 2025 Explores CGT Future

FDA accepts Sangamo's rolling BLA submission for Fabry

Australian government blocks Cosette's Mayne Pharma buy

Elanco's drug gets emergency nod to treat deadly Parasite in Cats

GSK, Anaptysbio sue each other over Jemperli revenue

AstraZeneca to onshore rare disease portfolio its $50B pledge

Takeda's Adzynma draws FDA scrutiny after paediatric death

Lilly is first drugmaker to reach $1 trillion valuation

FDA Study: Competitive Generics Launch Faster Than Other Generics

Manufacturing permissions after lapse of new drug status

Genentech's Giredestrant Shows Superior iDFS in Breast Cancer

Cosmo, Glenmark Obtain European Market Approval For Winlevi

Indian Pharma Sector Poised for A Global Leap Beyond Generics

Lupin Launches Long-Acting Risperidone In US

Zydus Lifesciences Receives USFDA Approval For Leuprolide Acetate

Zydus Gets FDA Nod For Diroximel Fumarate Capsules

Alembic Gets USFDA Nod For Dexlansoprazole Delayed-Release

Ingenus Pharma Launches First Generic Equivalent To Premarin

Innovent Bio's Weight-Loss Drug Succeeds In Phase 3 Trial

Genscript Biotech Global Forum London 2025 Explores CGT Future

FDA accepts Sangamo's rolling BLA submission for Fabry

GSK, Anaptysbio sue each other over Jemperli revenue

Fierce Biotech Layoff Tracker 2025: Ensoma, Applied Tx & More

Nurix Trims Staff As Trial For Lead BTK Degrader Kicks Off

Iovance Biotherapeutics Discloses Inducement Grants Per NASDAQ

Olema Oncology Joins 8Th Evercore Healthcare Conference

Supernus Pharma Joins Piper Sandler Healthcare Conference

Trialwire Boosts Clinical Trial Referrals During Holidays

HRV Pharma And Metrochem Forge Strategic CDMO Alliance

Antheia links with TAPI to scale biosynthetic drug ingredients

Supply Chain Ties, Bayer Biotech Incubator—Fierce Pharma Asia

Celltrion Earmarks $478M To Bolster US Manufacturing Capacity

Novartis To Set Up Manufacturing Hub In NC, Add 700 Jobs

Import Price Floor On Cards For Critical Pharma Inputs

Akums Q2 PAT falls 35.8% on CDMO biz growth, declining API prices

Lupin Unit Expands CDMO Business With Oncology Block In Vizag

NPPA Revokes Decision Denying GSK's Antifungal Formulation

Farmson Unveils ?300 Crore Acetic Anhydride Unit In Vadodara

Takeda's Adzynma draws FDA scrutiny after paediatric death

AIOCD Asks Traders To Strictly Comply With The Ban On 35 Fdcs

NABL Sets Terms For Labs To Obtain And Keep Accreditation

Piramal Pharma Solutions' UK Site Secures Renewed MHRA GMP

Texas Sues Sanofi, BMS Over 'Deceptive' Plavix Marketing

Regulator Tightens Rules on High-Risk Solvents Post Syrup Deaths

KSMSCL Strengthens Drug Procurement With Quarantine Measures

OTC Morning-After Pills Sold in Varying Doses with Warnings

Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad

AIOCD & RDCA Support Regulatory Crackdown On MTP & Narcotic Drug

Genai Boosts Data-Driven Clinical Decision-Making In Healthcare:

Sharecare Wins 22 Digital Health Awards In Fall 2025 Competition

CDC Orders Researchers To End All Monkey Studies: Science